Randomized phase II trial comparing two versus three doses of ondansetron when used in combination with dexamethasone in patients receiving cisplatin ≥ 100 mg/m2

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 17, Issue 3, 1994, Pages 269-272

  Tyson, L B ^a   Kris, M G ^a   Baltzer, L ^a   Pisters, K M W ^a   Rigas, J R ^a   Clark, R A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CISPLATIN; DEXAMETHASONE; ETOPOSIDE; FLUOROURACIL; MITOMYCIN; ONDANSETRON; VINBLASTINE;

ADULT; AGED; ANTIEMETIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; URTICARIA; VOMITING;

EID: 0028358044     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199406000-00018     Document Type: Article

References (0)